AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in cancer treatment
New Delhi, Feb 10: AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment […]
